Attendees from around the world will gather on Wednesday morning to get their questions answered from high-level industry experts. This interactive Plenary Session will begin the Conference as speakers address the current challenges in the global supply network.
Wednesday, 6 June, 09.00 - 12.30
Peter Bigelow, SHA, LLC
Peter is the President of SHA, a consulting firm to the Pharmaceutical Industry. Among other clients, he currently provides management consulting to Patheon Pharmaceuticals where he served as President for North America Commercial Operations from February, 2010 until November 2011. Peter also held the role of Interim CEO of Patheon from November 2010 to Feb 2011. Patheon is a leading Contract Manufacturing and Contract Research Organization serving the Pharmaceutical Industry with $700 million in Revenue and 4700 employees.
Prior to joining Patheon, Peter spent 14 years with Wyeth Pharmaceuticals. From 2003 to 2009 he was responsible for supply of Wyeth’s Consumer Healthcare products globally. The consumer supply network consisted of six manufacturing sites, external suppliers, technical support functions and supply chain. Wyeth Consumer Healthcare (now Pfizer Consumer Healthcare) included such well known brands as Advil, Centrum Vitamins, Chapstick and Robitussin. From 1995 to 2003 he served in a variety of senior Engineering and Operations roles for the Prescription Drug side of the Wyeth business.
Peter also spent 14 years at SmithKline Beecham (now GlaxoSmithKline) before joining Wyeth. His assignments included significant international project work in Europe and the Far East and operations experience with injectable product manufacturing.
Peter is a member of the International Leadership Forum of the ISPE and is a frequent speaker at Industry events. He has a BS in Mechanical Engineering from Villanova University and an MBA from Philadelphia University. Peter and his wife Lynn and their two children reside in Valley Forge, Pennsylvania.
Erin Mullen, RPh, PhD, CEM
Associate Vice President, RxResponse
Pharmaceutical Research and Manufacturers of America
Dr. Erin Mullen is the Associate Vice President, Rx Response for the Pharmaceutical Researchers and Manufacturers of America (PhRMA). Rx Response is an information-sharing forum comprised of pharmaceutical manufacturers, distributors, pharmacies, hospitals, disaster relief agencies and state/federal government agencies to help support the continuing provision of medicines to patients whose health is threatened by a severe public health emergency. In this role, Dr. Mullen is a member of the Institute of Medicine’s Forum on Medical and Public Health Preparedness for Catastrophic Events. She also has served as co-chair of the Healthcare Sector Coordinating Council (HSCC), an advisory council to DHS and HHS on matters of healthcare as Critical Infrastructure (2008-2011) and as the Healthcare representative to the Partnership for Critical Infrastructure Security.
Dr. Mullen is also a front-line disaster responder, serving as a member of the National Disaster Medical System (NDMS) as a Clinical Pharmacy Unit Leader with the Logistics Response Assistance Team. Her disaster deployments have included multiple hurricane responses, an extended deployment for Katrina/Rita, and the Haiti Earthquake.
Prior to joining PhRMA, Dr. Mullen practiced community pharmacy and was the first Public Health Preparedness Pharmacist for the Florida Department of Health, bringing her experience as a field responder and clinical care provider to address public health preparedness issues that require pharmaceuticals and pharmaceutical care, including mass prophylaxis/Strategic National Stockpile deployment, pandemic influenza, all-hazards disaster and catastrophic planning, and first responder protection.
Dr. Mullen graduated from the Massachusetts College of Pharmacy with a B.S. in Pharmacy in 1992. She earned her Ph.D. in Microbiology and Immunology from the University of Miami in 2000. She earned the Certified Emergency Manager designation from the International Association of Emergency Managers in 2011.
Vice President, Global Brand Protection and Supply Chain Integrity
Johnson & Johnson
Strategies for Brand Protection and Supply Chain Integrity
Ron Guido has 34 years experience in the health care industry with Johnson & Johnson. He has held executive positions in the areas of engineering, operations, sales, product marketing, international marketing, new business development, information technology and general management. His current role is Vice President, Global Brand Protection and Supply Chain Integrity for Johnson & Johnson where his group is responsible for anti-counterfeiting programs and policies. He is a Board member for a charitable medical organization known as Operation Smile, an advisor to the Rothman Institute of Entrepreneurial Studies at Farleigh Dickinson University, an instructor with the Rutgers University Strategic Health Care mini-MBATM program and holds three patents for medical devices. Ron has an undergraduate degree in Industrial Engineering from Rutgers University and a Masters in Management Engineering from New Jersey Institute of Technology.